Veritable, L.P.

SEC CIK: 0001300311
Latest filing: Nov 14, 2023

SEC filings (opens in a new tab)

GANX holding history

Gain Therapeutics, Inc. in every 13F filed by Veritable, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GANX overview All 13F holders of GANX Full Q3 2023 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2021

Holdings of GANX by Veritable, L.P., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−25,064−100.0%	Sold out	Holders
Q1 2022	25,064	$103.0K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	25,064	$136.0K	<0.1%	00.0%	Unchanged	Holders
Q3 2021	25,064	$187.0K	<0.1%	+25,064	New	Holders